Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01886872
Brief Title: Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

First Submitted : June 24, 2013
First Submitted that Met QC Criteria : June 24, 2013
First Posted : June 26, 2013 (Estimate)

Results First Submitted : September 30, 2019
Results First Submitted that Met QC Criteria : December 10, 2019
Results First Posted : December 30, 2019

Last Update Submitted that Met QC Criteria : September 25, 2021
Last Update Posted : September 28, 2021